Biotech startups in Australia
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Cauldron Ferm | Orange | Series A | $13.2M | 2026-03-24 |
| Omniscient Neurotechnology | Sydney | Series D | $13.4M | 2026-01-16 |
| HealthMatch | Surry Hills | Series C | $6.9M | 2022-09-12 |
| PolyActiva | Melbourne | Series C | $25.7M | 2025-05-30 |
| Aravax | Melbourne | Series B | $22.2M | 2024-01-23 |
| Levur | Sydney | Pre-seed | $780K | 2025-05-06 |
| Fremantle Seaweed | Fremantle | Seed | $1.5M | 2025-11-30 |
| MISTI | Melbourne | Pre-seed | $120K | 2023-09-15 |
8 rows of the CSV in 5 of its 18 columns.
- The 99 biotech startups in Australia have raised $952.0M in total.
- 10 of them closed their most recent round in the last 12 months, $362.6M combined.
- The largest of those rounds is AdvanCell's $315.0M Series D, dated July 2026.
- The most recent is Eudaemon Technologies' $3.1M seed round on 13 October 2026.
- Main Sequence Ventures is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 73 companies (74%).
- 38% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (67% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 99| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Cauldron Ferm | Cauldron Ferm scales precision fermentation prototypes up to commercial quantities through a bio-acceleration process. | Biotech | Orange | Series A | $13.2M | 2026-03-24 | $32.1M | SOSV, IQT, Horizons Ventures +1 | 11 to 50 | 2023 |
| Omniscient Neurotechnology | Omniscient Neurotechnology develops AI and data solutions with predictive analytics to improve brain disorder treatment. | Artificial intelligence | Sydney | Series D | $13.4M | 2026-01-16 | $57.2M | Base Capital | 51 to 100 | 2019 |
| Fremantle Seaweed | Fremantle Seaweed grows native seaweed species at a trial farm south of Gage Roads. | Biotech | Fremantle | Seed | $1.5M | 2025-11-30 | $4.9M | Western Australian Investment Attraction Fund | 1 to 10 | 2020 |
| SeaStock | SeaStock develops marine science solutions for producing and extracting substances from seaweed and algae. | Biotech | Fremantle | Seed | $482K | 2025-10-23 | $755K | MassChallenge Switzerland | 1 to 10 | 2021 |
| PolyActiva | PolyActiva develops products that enable drug release from medical devices. | Biotech | Melbourne | Series C | $25.7M | 2025-05-30 | $38.2M | Brandon Capital, Yuuwa Capital, Medical Research Commercialisation Fund (MRCF) +1 | 11 to 50 | 2009 |
| Bovotica | Bovotica works to reduce rumen microbiota in cattle to lower methane emissions. | Biotech | Brisbane | Seed | $3.4M | 2025-05-12 | $3.4M | SparkLabs Cultiv8 | 1 to 10 | 2023 |
| The Leaf Protein Company | The Leaf Protein Company produces high quality, sustainable plant-based protein ingredients. | Biotech | Adelaide | Pre-seed | $566K | 2024-06-12 | Big Idea Ventures, LaunchVic, Sproutx | 1 to 10 | 2020 | |
| Aravax | Aravax is an early stage biotechnology company developing a treatment for peanut allergy. | Biotech | Melbourne | Series B | $22.2M | 2024-01-23 | Novartis Venture Fund, Breakthrough Victoria, Uniseed +2 | 11 to 50 | 2015 | |
| Omni Biotech | Omni Biotech develops health and performance algorithms that run on all hardware platforms. | Biotech | Perth | Pre-seed | $300K | 2023-12-11 | Skalata | 1 to 10 | 2020 | |
| MISTI | MISTI develops low-cost, validated, rapid lung delivery systems. | Biotech | Melbourne | Pre-seed | $120K | 2023-09-15 | Startmate | 1 to 10 | 2022 | |
| HealthMatch | HealthMatch connects patients with new drugs and treatments. | Artificial intelligence | Surry Hills | Series C | $6.9M | 2022-09-12 | $27.5M | Square Peg Capital, January Capital, Folklore Ventures +1 | 11 to 50 | 2017 |
| Artrya | Artrya applies artificial intelligence to help clinicians diagnose Coronary Artery Disease faster and more accurately. | Artificial intelligence | Perth | Series A | $15.0M | 2021-05-25 | $15.0M | Regal Funds Management, Thorney Investment, Washington H. Soul Pattinson | 11 to 50 | 2019 |
Table 1. Biotech startups in Australia: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 99.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Omniscient Neurotechnology | Omniscient Neurotechnology develops AI and data solutions with predictive analytics to improve brain disorder treatment. | Artificial intelligence | Sydney | Series D | $13.4M | 2026-01-16 | $57.2M | Base Capital | 51 to 100 | 2019 |
| 2 | Cauldron Ferm | Cauldron Ferm scales precision fermentation prototypes up to commercial quantities through a bio-acceleration process. | Biotech | Orange | Series A | $13.2M | 2026-03-24 | $32.1M | SOSV, IQT, Horizons Ventures +1 | 11 to 50 | 2023 |
| 3 | Fremantle Seaweed | Fremantle Seaweed grows native seaweed species at a trial farm south of Gage Roads. | Biotech | Fremantle | Seed | $1.5M | 2025-11-30 | $4.9M | Western Australian Investment Attraction Fund | 1 to 10 | 2020 |
Table 2. Biotech startups in Australia: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Main Sequence Ventures | Venture capital firm | Sydney, Australia | 3 | 3% | 2 | Rainstick, Cauldron Ferm |
| 2 | Brandon Capital | Private equity firm | Melbourne, Australia | 2 | 2% | ||
| 3 | Uniseed | Venture capital firm | Brisbane, Australia | 2 | 2% | ||
| 4 | SparkLabs Cultiv8 | Startup accelerator | Orange, Australia | 2 | 2% | ||
| 5 | Startmate | Startup accelerator | Melbourne, Australia | 2 | 2% | 1 | Rainstick |
| 6 | Tin Alley Ventures | Venture capital firm | Carlton, Australia | 2 | 2% | ||
| 7 | Australian Medical Angels | Angel group | Sydney, Australia | 2 | 2% | ||
| 8 | SOSV | Venture capital firm | Princeton, United States | 1 | 1% | 1 | Cauldron Ferm |
| 9 | IQT | Startup accelerator | Arlington, United States | 1 | 1% | 1 | Cauldron Ferm |
| 10 | Horizons Ventures | Venture capital firm | Hong Kong | 1 | 1% | 1 | Cauldron Ferm |
| 11 | Base Capital | Venture capital firm | Cape Town, South Africa | 1 | 1% | 1 | Omniscient Neurotechnology |
| 12 | Athletic Ventures | Syndicate | Sydney, Australia | 1 | 1% | ||
| 13 | Folklore Ventures | Venture capital firm | Sydney, Australia | 1 | 1% | ||
| 14 | January Capital | Venture capital firm | Singapore | 1 | 1% | ||
| 15 | Square Peg Capital | Venture capital firm | Surry Hills, Australia | 1 | 1% |
Table 3. Biotech startups in Australia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 73 | 74% | $873.0M |
| Software | 15 | 15% | $100.2M |
| Artificial intelligence | 8 | 8% | $100.0M |
| Hardware | 2 | 2% |
Table 4. Biotech startups in Australia by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 16 | 16% | $566K |
| Seed | 54 | 55% | $1.9M |
| Series A | 17 | 17% | $15.0M |
| Series B | 7 | 7% | $22.2M |
| Series C | 2 | 2% | $25.7M |
| Series D+ | 3 | 3% | $31.8M |
Table 5. Biotech startups in Australia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups in Australia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 10% | $3.1M |
| September 2026 | 1 | 10% | $8.3M |
| August 2026 | 1 | 10% | |
| July 2026 | 1 | 10% | $315.0M |
| June 2026 | 1 | 10% | $2.0M |
| April 2026 | 1 | 10% | |
| March 2026 | 1 | 10% | $13.2M |
| January 2026 | 1 | 10% | $13.4M |
| December 2025 | 1 | 10% | $6.0M |
| November 2025 | 1 | 10% | $1.5M |
Table 7. Biotech startups in Australia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 8% | $355.1M |
| 2025 | 16 | 16% | $109.4M |
| 2024 | 8 | 8% | $44.6M |
| 2023 | 10 | 10% | $84.5M |
| 2022 | 11 | 11% | $50.2M |
| 2021 | 7 | 7% | $16.3M |
Table 8. Biotech startups in Australia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 13 | 13% |
| 2020 to 2022 | 24 | 25% |
| 2015 to 2019 | 36 | 37% |
| 2010 to 2014 | 16 | 16% |
| Before 2010 | 8 | 8% |
Table 9. Biotech startups in Australia by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 64 | 67% |
| 11 to 50 | 23 | 24% |
| 51 to 100 | 4 | 4% |
| 101 to 250 | 4 | 4% |
Table 10. Biotech startups in Australia by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Australia. On 16 November 2026 that is 99 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 99 rows: 36 have no round amount, 0 no city and 50 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Australia are on the list?
- 99, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 99 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.